Articles From: AV Homes Reports Results for Third Quarter 2014 to AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical


Third Quarter 2014 Highlights - as compared to the prior year quarter (unless otherwise noted) SCOTTSDALE, Ariz., Oct.
Sign-up for AV Homes Reports Results for Third Quarter 2014 investment picks
SCOTTSDALE, Ariz., Oct.
Sign-up for AV Homes, Inc. Announces Third Quarter 2014 Earnings Call investment picks
http://media.marketwire.com/attachments/201408/272408_logo-2.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1165544&ProfileId=051205&sourceType=1 LA JOLLA, CA --
Sign-up for AV1 Group Enters Into Definitive Agreement to Acquire www.VaporHighUSA.com investment picks
http://media.marketwire.com/attachments/201408/272408_logo-2.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164189&ProfileId=051205&sourceType=1 LA JOLLA, CA --
Sign-up for AV1 Group Releases Update to Shareholders on Recent Developments and Strategies investment picks
2014/11/18
SAN JOSE, Calif., SINGAPORE and SANTA CLARA, Calif., Nov.
Sign-up for Avago Completes Sale of LSI's Axxia Networking Business and Related Assets to Intel for $650 Million investment picks
SAN JOSE, Calif., and SINGAPORE, Jan.
Sign-up for Avago Demonstrates Industry-Leading 56Gbps PAM4 SerDes investment picks
SAN JOSE, Calif., and SINGAPORE, Dec.
Sign-up for Avago Technologies Announces $0.35 Interim Dividend investment picks
Quarterly net revenue from continuing operations up 25 percent sequentially Quarterly GAAP gross margin from continuing operations of 50 percent; Quarterly Non-GAAP gross margin from continuing operations of 58 percent Quarterly GAAP diluted EPS from continuing operations of $0.50; Quarterly Non-GAAP diluted EPS from continuing operations of $1.99 SAN JOSE, Calif.
Sign-up for Avago Technologies Limited Announces Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
2014/12/4
Seppy Basili, Kaplan Test Prep’s vice president of college admissions and K12 programs, is available to speak with interested journalists regarding the company’s participation in today’s White House College Opportunity Day of Action and Kaplan’s commitment to the First Lady’s “Reach Higher” Campaign.
Sign-up for Available for Interview: Kaplan College Admissions Expert on Committing College Readiness Resources to FLOTUS Reach Higher Campaign investment picks
MENLO PARK, Calif., Jan.
Sign-up for Avalanche Biotechnologies Prices Public Offering of $141.6 Million of Common Stock investment picks
MENLO PARK, Calif., Oct.
Sign-up for Avalanche Biotechnologies to Participate in Nomura's Biotechnology Conference investment picks
MENLO PARK, Calif., Nov.
Sign-up for Avalanche Biotechnologies to Present at the 26th Annual Piper Jaffray Healthcare Conference investment picks
MENLO PARK, Calif., Nov.
Sign-up for Avalanche Biotechnologies to Present at the Jefferies Global Healthcare Conference investment picks
MENLO PARK, Calif., Nov.
Sign-up for Avalanche Biotechnologies, Inc. Reports Third Quarter 2014 Financial Results investment picks
2014/12/2
WARREN, Ohio , Dec.
Sign-up for Avalon Holdings Corporation Announces Organizational Changes investment picks
2014/11/13
WARREN, Ohio , Nov.
Sign-up for Avalon Holdings Corporation Announces Third Quarter Results investment picks
AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) announced today the final income allocations of the Company’s 2014 dividend distributions on its Common Stock.
Sign-up for AvalonBay Communities Announces 2014 Dividend Income Tax Treatment investment picks
AVALONBAY COMMUNITIES, INC.
Sign-up for AvalonBay Communities Announces Fourth Quarter 2014 Earnings Release Date investment picks
AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) announced today that it priced a $300 million offering of unsecured notes (the “Notes”) with a maturity of November 15, 2024 under its existing shelf registration statement.
Sign-up for AvalonBay Communities Prices $300 Million Unsecured Notes Offering investment picks
AvalonBay Communities, Inc. (NYSE: AVB) announced today that Terry S.
Sign-up for AvalonBay Communities, Inc. Announces Appointment of Terry S. Brown as New Independent Director investment picks
AvalonBay Communities, Inc. (NYSE: AVB) announced today that Matthew H.
Sign-up for AvalonBay Communities, Inc. Announces Changes in Executive Officer Titles investment picks
AvalonBay Communities, Inc. (NYSE: AVB) (the “Company”) reported today Net Income Attributable to Common Stockholders for the quarter ended September 30, 2014 of $241,100,000. This resulted in Earnings per Share – diluted (“EPS”) of $1.83 for the three months ended September 30, 2014, compared to a loss of $0.08 per share for the comparable period of 2013.
Sign-up for AvalonBay Communities, Inc. Announces Third Quarter 2014 Operating Results investment picks
AvalonBay Communities, Inc. (NYSE: AVB) announced today that its Board of Directors declared a cash dividend on the Company’s Common Stock (par value $0.01 per share) for the fourth quarter of 2014.
Sign-up for AvalonBay Communities, Inc. Declares Fourth Quarter 2014 Dividends investment picks
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) breached their fiduciary duties in connection with the planned merger of the Company with Otsuka Pharmaceutical Co., Ltd.
Sign-up for AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AV Homes Reports Results for Third Quarter 2014 to AVANIR ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Avanir Pharmaceuticals, Inc. to Otsuka Pharmaceutical
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent